The Addition of Gemcitabine to 131I-MIBG Therapy in Pediatric Patients with Relapsed or Progressive Neuroblastoma: An International Multi-Centre Phase II Trial (MIBG-GEM)

N. Van Eijkelenburg, L. Tytgat, M. van Noesel, T. Simon, B. Hero, C. K. Li, B. De Keizer, A. C. J. Ammerlaan, M. Lopez-Yurda, C. M. Zwaan

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S343-S344
JournalPediatric Blood & Cancer
Volume66
Publication statusPublished - Dec 2019

Cite this